Get started
Anavex Life Sciences Corp.Anavex Life Sciences Corp.Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AVXL chart


Full chart

AVXL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪718.64 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.50 USD
Net income (FY)
‪−47.51 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪82.10 M‬
Beta (1Y)
2.39

Employees


Employees (FY)
40
Change (1Y)
+2 +5.26%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.19 M‬ USD

About Anavex Life Sciences Corp.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher U. Missling
Website
anavex.com
Headquarters
New York
Founded
2004
FIGI
BBG000C9K8K4
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AVXL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AVXL is 8.48 USD — it has increased by 2.85% in the past 24 hours. Watch Anavex Life Sciences Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anavex Life Sciences Corp. stocks are traded under the ticker AVXL.
AVXL stock has fallen by −7.38% compared to the previous week, the month change is a 50.53% rise, over the last year Anavex Life Sciences Corp. has showed a 21.08% increase.
We've gathered analysts' opinions on Anavex Life Sciences Corp. future price: according to them, AVXL price has a max estimate of 46.00 USD and a min estimate of 15.00 USD. Watch AVXL chart and read a more detailed Anavex Life Sciences Corp. stock forecast: see what analysts think of Anavex Life Sciences Corp. and suggest that you do with its stocks.
AVXL reached its all-time high on Jun 28, 2021 with the price of 31.50 USD, and its all-time low was 0.60 USD and was reached on Dec 1, 2014. View more price dynamics on AVXL chart.
See other stocks reaching their highest and lowest prices.
AVXL stock is 5.34% volatile and has beta coefficient of 2.39. Track Anavex Life Sciences Corp. stock price on the chart and check out the list of the most volatile stocks — is Anavex Life Sciences Corp. there?
Today Anavex Life Sciences Corp. has the market capitalization of ‪698.72 M‬, it has increased by 15.79% over the last week.
Yes, you can track Anavex Life Sciences Corp. financials in yearly and quarterly reports right on TradingView.
Anavex Life Sciences Corp. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
AVXL earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.16 USD resulting in a 12.50% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Anavex Life Sciences Corp. earnings.
Anavex Life Sciences Corp. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
AVXL net income for the last quarter is ‪−12.21 M‬ USD, while the quarter before that showed ‪−10.55 M‬ USD of net income which accounts for −15.82% change. Track more Anavex Life Sciences Corp. financial stats to get the full picture.
No, AVXL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 40.00 employees. See our rating of the largest employees — is Anavex Life Sciences Corp. on this list?
Like other stocks, AVXL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anavex Life Sciences Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Anavex Life Sciences Corp. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Anavex Life Sciences Corp. stock shows the buy signal. See more of Anavex Life Sciences Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.